GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tilray Brands Inc (TSX:TLRY) » Definitions » YoY EPS Growth

Tilray Brands (TSX:TLRY) YoY EPS Growth : 59.26% (As of Aug. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Tilray Brands YoY EPS Growth?

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months. Tilray Brands's YoY EPS Growth for the quarter that ended in Aug. 2024 was 59.26%.

Tilray Brands's Earnings per Share (Diluted) for the three months ended in Aug. 2024 was C$-0.06.

Tilray Brands YoY EPS Growth Historical Data

The historical data trend for Tilray Brands's YoY EPS Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tilray Brands YoY EPS Growth Chart

Tilray Brands Annual Data
Trend May15 May16 May17 May18 May19 May20 May21 May22 May23 May24
YoY EPS Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only -171.49 -150.99 22.80 -149.49 85.80

Tilray Brands Quarterly Data
Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24 May24 Aug24
YoY EPS Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.64 35.14 93.66 72.91 59.26

Tilray Brands YoY EPS Growth Calculation

YoY EPS Growth is the percentage change of Earnings per Share (Diluted) over the past twelve months.

Tilray Brands's YoY EPS Growth for the fiscal year that ended in May. 2024 is calculated as:

YoY EPS Growth (A: May. 2024 )
=(Earnings per Share (Diluted) (A: May. 2024 )-Earnings per Share (Diluted) (A: May. 2023 ))/ | Earnings per Share (Diluted) (A: May. 2023 ) |
=(-0.451--3.176)/ | -3.176 |
=85.80 %

Tilray Brands's YoY EPS Growth for the quarter that ended in Aug. 2024 is calculated as:

YoY EPS Growth (Q: Aug. 2024 )
=(Earnings per Share (Diluted) (Q: Aug. 2024 )-Earnings per Share (Diluted) (Q: Aug. 2023 )) / | Earnings per Share (Diluted) (Q: Aug. 2023 )) |
=(-0.055--0.135)/ | -0.135 |
=59.26 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Tilray Brands YoY EPS Growth Related Terms

Thank you for viewing the detailed overview of Tilray Brands's YoY EPS Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Tilray Brands Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tilray Brands Inc (TSX:TLRY) » Definitions » YoY EPS Growth
Comparable Companies
TARO PCRX SUPN ANIP IRWD DCPH AVDL COLL DVAX AMRX ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
TLRY:USA 2HQ:Germany TLRY:Austria
Address
265 Talbot Street West, Leamington, ON, CAN, N8H 5L4
Website
https://www.tilray.com
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol.